UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_____________________
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES AND EXCHANGE ACT OF 1934
November 21, 2002
Date of Report (Date of earliest event reported)
_____________________
NEOTHERAPEUTICS, INC.
(Exact name of registrant as specified in its charter)
Delaware 000-28782 93-0979187
(State or other Jurisdiction (Commission File Number) (IRS Employer
of Incorporation) Identification Number)
157 Technology Drive 92618
Irvine, California (Zip Code)
(Address of principal executive offices)
(949) 788-6700
(Registrant's telephone number, including area code)
N/A
(Former Name or Former Address, if Changed Since Last Report
Item 5. Other Events
On November 21, 2002, NeoTherapeutics, Inc. ("NeoTherapeutics")
issued a press release announcing that it had issued 356,956 shares of common
stock in a private placement to settle $628,190.09 in vendor payables. A copy of
the press release is attached hereto as Exhibit 99.1 and incorporated herein by
this reference.
Item 7(c). Exhibits
Exhibits:
--------
4.1 Form of Settlement Agreement and Release
4.2 Settlement Agreement and Release dated as of October 22, 2002 by and
between NeoTherapeutics, Inc. and Symbion Research International,
Inc.
99.1 Press release dated November 21, 2002
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
NEOTHERAPEUTICS, INC.
Date: November 21, 2002 By: /s/ Rajesh C. Shrotriya
-----------------------------------
Name: Rajesh C. Shrotriya, M.D.
Title: Chairman of the Board,
Chief Executive Officer and President
EXHIBIT INDEX
Exhibits:
--------
4.1 Form of Settlement Agreement and Release
4.2 Settlement Agreement and Release dated as of October 22, 2002 by
and between NeoTherapeutics, Inc. and Symbion Research
International, Inc.
99.1 Press release dated November 21, 2002